These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26291519)

  • 1. Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years.
    Potosky AL; O'Neill SC; Isaacs C; Tsai HT; Chao C; Liu C; Ekezue BF; Selvam N; Kessler LG; Zhou Y; Schwartz MD
    Cancer; 2015 Nov; 121(22):4062-70. PubMed ID: 26291519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapy.
    MacDonald KV; Bombard Y; Deal K; Trudeau M; Leighl N; Marshall DA
    Eur J Cancer; 2016 Jul; 61():85-93. PubMed ID: 27155447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations.
    Panattoni L; Lieu TA; Jayasekera J; O'Neill S; Mandelblatt JS; Etzioni R; Phelps CE; Ramsey SD
    Breast Cancer Res Treat; 2019 Jan; 173(2):417-427. PubMed ID: 30306429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world economic value of a 21-gene assay in early-stage breast cancer.
    Waintraub SE; McNamara D; Graham DMA; Pecora AL; Min J; Wu T; Noh HG; Connors J; Pe Benito R; Choi K; Schultz E; Goldberg SL
    Am J Manag Care; 2017 Dec; 23(12):e416-e420. PubMed ID: 29261249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
    Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
    JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes over time in the impact of gene-expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A nationwide study.
    Kuijer A; Drukker CA; Elias SG; Smorenburg CH; Th Rutgers EJ; Siesling S; van Dalen T
    Int J Cancer; 2016 Aug; 139(4):769-75. PubMed ID: 27062369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
    Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
    J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of oncotype DX recurrence score in the management of breast cancer cases.
    Nguyen MT; Stessin A; Nagar H; D'Alfonso TM; Chen Z; Cigler T; Hayes MK; Shin SJ
    Clin Breast Cancer; 2014 Jun; 14(3):182-90. PubMed ID: 24486121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment.
    Marshall DA; Deal K; Bombard Y; Leighl N; MacDonald KV; Trudeau M
    BMJ Open; 2016 Jun; 6(6):e010981. PubMed ID: 27256091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65.
    O'Neill SC; Isaacs C; Lynce F; Graham DM; Chao C; Sheppard VB; Zhou Y; Liu C; Selvam N; Schwartz MD; Potosky AL
    Breast Cancer Res; 2017 Mar; 19(1):45. PubMed ID: 28359319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of gene-expression profiling in patients with early breast cancer when applied outside the guideline directed indication area.
    Schreuder K; Kuijer A; Rutgers EJT; Smorenburg CH; van Dalen T; Siesling S
    Eur J Cancer; 2017 Oct; 84():270-277. PubMed ID: 28844015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of 21-gene recurrence score assay and adjuvant chemotherapy use in the medicare population, 2008-2011.
    Su KW; Hall J; Soulos PR; Abu-Khalaf MM; Evans SB; Mougalian SS; Rutter CE; Davidoff AJ; Gross CP
    J Geriatr Oncol; 2016 Jan; 7(1):15-23. PubMed ID: 26704661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care.
    Haas JS; Liang SY; Hassett MJ; Shiboski S; Elkin EB; Phillips KA
    Breast Cancer Res Treat; 2011 Nov; 130(2):619-26. PubMed ID: 21681446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.
    Hassett MJ; Silver SM; Hughes ME; Blayney DW; Edge SB; Herman JG; Hudis CA; Marcom PK; Pettinga JE; Share D; Theriault R; Wong YN; Vandergrift JL; Niland JC; Weeks JC
    J Clin Oncol; 2012 Jun; 30(18):2218-26. PubMed ID: 22585699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study.
    Kuchel A; Robinson T; Comins C; Shere M; Varughese M; Sparrow G; Sahu A; Saunders L; Bahl A; Cawthorn SJ; Braybrooke JP
    Br J Cancer; 2016 Mar; 114(7):731-6. PubMed ID: 26954715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underutilization of gene expression profiling for early-stage breast cancer in California.
    Cress RD; Chen YS; Morris CR; Chew H; Kizer KW
    Cancer Causes Control; 2016 Jun; 27(6):721-7. PubMed ID: 27097910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.
    Levine MN; Julian JA; Bedard PL; Eisen A; Trudeau ME; Higgins B; Bordeleau L; Pritchard KI
    J Clin Oncol; 2016 Apr; 34(10):1065-71. PubMed ID: 26598746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer.
    Le Du F; Gonzalez-Angulo AM; Park M; Liu DD; Hortobagyi GN; Ueno NT
    Clin Breast Cancer; 2015 Dec; 15(6):458-66. PubMed ID: 26233757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer.
    Rutter CE; Yao X; Mancini BR; Aminawung JA; Chagpar AB; Saglam O; Hofstatter EW; Abu-Khalaf M; Gross CP; Evans SB
    Clin Breast Cancer; 2016 Feb; 16(1):59-62. PubMed ID: 26483315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.